Letter to the editor

Immune therapy trials for malignant brain tumors are challenging to undertake and there are many factors, including the high expense per patient which limits the number of patients enrolled, hence curtailing the ability to demonstrate that the intervention improves clinical outcomes. Profiling the i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal for immunotherapy of cancer 2014-07, Vol.2 (1)
Hauptverfasser:	Fadul, Camilo E, Fisher, Jan L, Hampton, Thomas H, Ernstoff, Marc S
Format:	Artikel
Sprache:	eng
Schlagworte:	Brain cancer Cancer Cancer therapies Clinical trials Dendritic cells Immunotherapy Medical prognosis Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!